Medication info
Hanmim Sitaglipton 100 mg (Sitagliptin Hydrochloride Hydrate)

Hanmim Sitaglipton 100 mg (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.4mg / 1 tablet
Manufacturer / importer
Hanlim Pharmaceutical Co., Ltd.
Appearance
Pale orange, round, biconvex film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP × 3]
Approval status
Active

MFDS item code 202004062 · Approved 2020.05.29 · Insurance code 645306380

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
For monotherapy or combination therapy, administer 100 mg once daily; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, section 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is required, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dosage adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Hanlim Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • difficulty in blood sugar control
View approved original text

This medication is used in conjunction with diet and exercise to help control blood sugar in patients with type 2 diabetes. It can be used as monotherapy, but if blood sugar control is challenging in patients who have not taken diabetes medications before, it may be combined with metformin. Additionally, it is added to therapy for patients whose blood sugar control is insufficient with monotherapy using sulfonylureas, metformin, thiazolidinediones, or insulin. It is also used when blood sugar control is difficult in more complex combinations, thereby enhancing the therapeutic effect. Thus, this medication is used in various treatment situations to improve blood sugar control.

How to take

Adult dose

For monotherapy or combination therapy, administer 100 mg once daily; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, section 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is required, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dosage adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication may rarely cause severe allergic reactions, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or lips occur after taking the medication, you should stop taking it immediately and consult a healthcare professional. This medication may cause a serious side effect known as pancreatitis, which is inflammation of the pancreas. If severe abdominal pain, vomiting, or loss of appetite occur during treatment, you should notify your doctor immediately. It should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and it should be avoided in individuals who are allergic to this medication or any of its components. Patients with reduced kidney function need dosage adjustments; thus, those with kidney disease or impaired renal function should always consult healthcare professionals beforehand. During treatment, symptoms similar to a cold such as headache, indigestion, diarrhea, etc. may occur, as well as symptoms of low blood sugar, so blood glucose monitoring must be cautious. Especially, when used in conjunction with insulin or sulfonylureas, the risk of hypoglycemia increases, hence it is necessary to frequently monitor blood glucose levels and adjust the dose if necessary. Severe joint pain or a rare side effect with blisters on the skin has been reported, and if these symptoms occur, you should consult a doctor immediately and stop taking the medication. It is advisable for pregnant or breastfeeding women not to take this medication, and safety for children or adolescents under 18 has not been established. Elderly patients may require dose adjustments and regular kidney function testing due to the possibility of reduced kidney function. In the case of overdose, as there is no specific antidote, you should visit a medical facility immediately for appropriate treatment and monitoring, and some medications may be removed through dialysis. This medication does not have significant interactions when taken with many other drugs; however, when taking certain medications, disclose to healthcare professionals and appropriate management is necessary. The cardiovascular safety of this medication has been confirmed; however, if any abnormal symptoms occur during use, you should immediately consult a healthcare professional.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory tract infection
  • nasopharyngitis
  • headache
  • diarrhea
  • abdominal pain
Show 27 more
  • nausea
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • vesicular pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased blood triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that is not exposed to air, and it is advisable to maintain a temperature between 1 and 30 degrees Celsius. Proper storage maintains the drug's effectiveness and safety.

Appearance and packaging

Appearance

Pale orange, round, biconvex film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP × 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.